Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Assets: 2012-2024

Historic Current Assets for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $114.6 million.

  • CorMedix's Current Assets rose 254.78% to $259.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.5 million, marking a year-over-year increase of 254.78%. This contributed to the annual value of $114.6 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Current Assets stood at $114.6 million for FY2024, which was up 92.40% from $59.6 million recorded in FY2022.
  • In the past 5 years, CorMedix's Current Assets registered a high of $114.6 million during FY2024, and its lowest value of $48.2 million during FY2020.
  • For the 2-year period, CorMedix's Current Assets averaged around $87.1 million, with its median value being $87.1 million (2022).
  • Its Current Assets has fluctuated over the past 5 years, first spiked by 64.17% in 2020, then fell by 10.41% in 2022.
  • Over the past 4 years, CorMedix's Current Assets (Yearly) stood at $48.2 million in 2020, then spiked by 37.95% to $66.5 million in 2021, then dropped by 10.41% to $59.6 million in 2022, then reached $114.6 million in 2024.